Next |
home / stock / revb / revb message board
Subject | By | Source | When |
---|---|---|---|
Ready for another move $1.08 entry consideration. $2.05 to | tw0122 | investorshub | 04/18/2023 11:07:48 AM |
Patience gonna pay - this is and still | Klinsmann | investorshub | 04/17/2023 4:04:08 PM |
DOESN'T LOOK IT !! | power11 | investorshub | 04/17/2023 4:02:27 PM |
Agree. Ripe for a VICIOUS reversal. | Lonewolf1 | investorshub | 04/17/2023 3:02:32 PM |
Any update and its going to explode... | Klinsmann | investorshub | 04/17/2023 3:00:40 PM |
MAYBE ?? | power11 | investorshub | 04/17/2023 2:31:07 PM |
Something is definitely up here. The volume says it | Lonewolf1 | investorshub | 04/17/2023 2:03:27 PM |
My first call on it was too early... | Klinsmann | investorshub | 04/17/2023 1:36:32 PM |
NICE POP TO 2.45 NOW 1.30 | TheFinalCD | investorshub | 04/17/2023 11:13:11 AM |
znewcar1: $REVB Hod 1.2100 RL.95=LL Last Post: 10/25/2022 5:19:48 PM Board Marks: 0 Posts Today: 0 B | znewcar1 | investorshangout | 04/14/2023 5:27:29 PM |
Hope so | Arnold25764 | investorshub | 03/20/2023 5:13:34 PM |
Markets need to turn in general. I still | Klinsmann | investorshub | 03/20/2023 12:06:58 PM |
Hoping for it. So far Deep Red days. | Arnold25764 | investorshub | 03/18/2023 1:06:11 AM |
A summary: | Klinsmann | investorshub | 02/28/2023 7:57:39 PM |
What about some deep green days making you | Klinsmann | investorshub | 02/28/2023 7:48:21 PM |
We ever going to see a string of | Arnold25764 | investorshub | 02/28/2023 7:32:41 PM |
Nobody here?!? Its a pity - this gonna | Klinsmann | investorshub | 02/28/2023 4:41:14 PM |
Added even more. This stock gonna generate very | Klinsmann | investorshub | 02/27/2023 5:35:00 PM |
In! Offering closes today... | Klinsmann | investorshub | 02/13/2023 3:00:46 PM |
Somebody has been loading here. | Lonewolf1 | investorshub | 01/27/2023 1:35:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
OTCMKTS Market:
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March 31, ...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...
– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or ...